End-of-day quote
Shanghai S.E.
18:00:00 2024-05-06 EDT
|
5-day change
|
1st Jan Change
|
17.9
CNY
|
+1.13%
|
|
+6.42%
|
-25.76%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Capitalization
1 |
5,319
|
8,417
|
6,061
|
5,438
|
3,961
|
Enterprise Value (EV)
1 |
5,319
|
8,417
|
6,061
|
5,438
|
3,961
|
P/E ratio
|
28.3
x
|
26.4
x
|
20.1
x
|
43.8
x
|
5.85
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
10,846,992
x
|
-
|
5,346,558
x
|
8,054,306
x
|
-
|
EV / Revenue
|
10,846,992
x
|
-
|
5,346,558
x
|
8,054,306
x
|
-
|
EV / EBITDA
|
26,916,475
x
|
-
|
15,764,592
x
|
29,260,535
x
|
-
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
2.7
x
|
-
|
2.58
x
|
2.42
x
|
-
|
Nbr of stocks (in thousands)
|
225,562
|
225,562
|
225,562
|
225,562
|
225,562
|
Reference price
2 |
23.58
|
37.32
|
26.87
|
24.11
|
17.56
|
Announcement Date
|
21-04-25
|
22-03-30
|
23-04-24
|
24-04-26
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Net sales
|
602
|
490.3
|
-
|
1,134
|
675.2
|
-
|
EBITDA
|
-
|
197.6
|
-
|
384.5
|
185.9
|
-
|
EBIT
|
-
|
173.8
|
-
|
346.3
|
138.8
|
-
|
Operating Margin
|
-
|
35.44%
|
-
|
30.55%
|
20.56%
|
-
|
Earnings before Tax (EBT)
|
-
|
182.9
|
-
|
346.4
|
141.3
|
-
|
Net income
1 |
-
|
157.3
|
319.4
|
301.7
|
123.4
|
690
|
Net margin
|
-
|
32.09%
|
-
|
26.62%
|
18.28%
|
-
|
EPS
2 |
1.297
|
0.8345
|
1.414
|
1.340
|
0.5500
|
3.000
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
20-08-10
|
21-04-25
|
22-03-30
|
23-04-24
|
24-04-26
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
14.2%
|
-
|
13.4%
|
5.37%
|
-
|
ROA (Net income/ Total Assets)
|
-
|
11.2%
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
1,409
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
-
|
8.720
|
-
|
10.40
|
9.960
|
-
|
Cash Flow per Share
|
-
|
0.6800
|
-
|
1.330
|
0.7900
|
-
|
Capex
|
-
|
52.7
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
10.75%
|
-
|
-
|
-
|
-
|
Announcement Date
|
20-08-10
|
21-04-25
|
22-03-30
|
23-04-24
|
24-04-26
|
-
|
|
1st Jan change
|
Capi.
|
---|
| -25.76% | 559M | | +18.00% | 66.51B | | +0.80% | 48.47B | | +17.14% | 41.43B | | +22.33% | 27.19B | | +11.38% | 19.82B | | +4.54% | 18.15B | | -22.01% | 15.98B | | +4.12% | 15.53B | | -10.13% | 15.46B |
Other Specialty Chemicals
|